UCLA Researchers Awarded $1.7 Million Department of Defense Grant to Advance Next-Generation CAR T-Cell Therapies for Prostate Cancer

Researchers from the UCLA Health Jonsson Comprehensive Cancer Center have received a $1.7 million grant from the US Department of Defense’s Congressionally Directed Medical Research Programs to develop new strategies to improve CAR T-cell therapies for metastatic CRPC.